Shimoishi Koichiro, Muto Yasuhiko, Asakage Masahiro, Yamada Yoshinao
Dept. of Surgery, Odaira Memorial Tokyo Hitachi Hospital, Japan.
Gan To Kagaku Ryoho. 2012 Jul;39(7):1127-30.
The patient was a 72-year-old woman, admitted to our hospital due to appetite loss. We performed gastroscopy, colonoscopy and abdominal CT. She had both advanced ascending colon cancer with multiple liver metastasis(cStage IV: cT3N1H3)and early gastric cancer(cStage 0: cTisN0M0). She received chemotherapy with modified FOLFOX6(mFOLFOX6), and the chemotherapy was judged effective for her gastric cancer. During the next 6 months, a total of 10 courses had been performed. The tumor marker scores(CEA, CA19-9)decreased significantly. Gastric cancer was diagnosed as CR(complete response)in gastroscopy after 6 courses of chemotherapy. In this case, chemotherapy with mFOLFOX6 was effective for gastric cancer.
患者为一名72岁女性，因食欲减退入住我院。我们进行了胃镜、结肠镜和腹部CT检查。她患有晚期升结肠癌伴多发肝转移（临床分期IV期：cT3N1H3）和早期胃癌（临床分期0期：cTisN0M0）。她接受了改良FOLFOX6（mFOLFOX6）化疗，化疗被判定对她的胃癌有效。在接下来的6个月里，共进行了10个疗程。肿瘤标志物评分（CEA、CA19-9）显著下降。化疗6个疗程后，胃镜检查显示胃癌诊断为完全缓解（CR）。在这种情况下，mFOLFOX6化疗对胃癌有效。
